Modelling intensive care unit capacity under different epidemiological scenarios of the COVID-19 pandemic in three Western European countries. by McCabe, Ruth et al.
COVID-19
Modelling intensive care unit capacity under
different epidemiological scenarios of the
COVID-19 pandemic in three Western European
countries
Ruth McCabe ,1,2,3*† Mara D Kont ,1† Nora Schmit ,1†
Charles Whittaker ,1 Alessandra Løchen ,1 Marc Baguelin ,1
Edward Knock ,1 Lilith K Whittles ,1,4,5 John Lees ,1
Nicholas F Brazeau ,1 Patrick GT Walker ,1 Azra C Ghani ,1
Neil M Ferguson ,1,4 Peter J White ,1,4,5 Christl A Donnelly ,1,2,3,4
Katharina Hauck 1,4 and Oliver J Watson 1
1MRC Centre for Global Infectious Disease Analysis & WHO Collaborating Centre for Infectious
Disease Modelling, Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College
London, St Mary’s Campus, Norfolk Place, London, UK, 2Department of Statistics, University of Oxford,
Oxford, UK, 3NIHR Health Research Protection Unit in Emerging and Zoonotic Diseases, The Ronald
Ross Building, University of Liverpool, Liverpool, UK, 4NIHR Health Research Protection Unit in
Modelling and Health Economics, Imperial College London, St Mary’s Campus, Norfolk Place, London,
UK and 5 Modelling and Economics Unit, National Infection Service, Public Health England, London, UK
†Joint first authors
*Corresponding author. Department of Statistics, University of Oxford, 24-29 St Giles’, Oxford, OX1 3LB, UK. E-mail:
ruth.mccabe@stats.ox.ac.uk
Received 2 December 2020; editorial decision 10 February 2021; Accepted 23 February 2021
Abstract
Background: The coronavirus disease 2019 (COVID-19) pandemic has placed enormous
strain on intensive care units (ICUs) in Europe. Ensuring access to care, irrespective of
COVID-19 status, in winter 2020–2021 is essential.
Methods: An integrated model of hospital capacity planning and epidemiological projec-
tions of COVID-19 patients is used to estimate the demand for and resultant spare capac-
ity of ICU beds, staff and ventilators under different epidemic scenarios in France,
Germany and Italy across the 2020–2021 winter period. The effect of implementing lock-
downs triggered by different numbers of COVID-19 patients in ICUs under varying levels
of effectiveness is examined, using a ‘dual-demand’ (COVID-19 and non-COVID-19) pa-
tient model.
Results: Without sufficient mitigation, we estimate that COVID-19 ICU patient numbers
will exceed those seen in the first peak, resulting in substantial capacity deficits, with
beds being consistently found to be the most constrained resource. Reactive lockdowns
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could lead to large improvements in ICU capacity during the winter season, with pres-
sure being most effectively alleviated when lockdown is triggered early and sustained
under a higher level of suppression. The success of such interventions also depends on
baseline bed numbers and average non-COVID-19 patient occupancy.
Conclusion: Reductions in capacity deficits under different scenarios must be weighed
against the feasibility and drawbacks of further lockdowns. Careful, continuous decision-
making by national policymakers will be required across the winter period 2020–2021.
Key words: COVID-19, intensive care, epidemiological modelling, hospital capacity, non-pharmaceutical
interventions
Introduction
National healthcare systems are under extreme pressure due to
the coronavirus disease 2019 (COVID-19) pandemic. To
avoid overwhelming hospitals at the beginning of the pan-
demic, countries implemented stringent non-pharmaceutical
interventions (NPIs) including physical distancing and national
lockdowns. Although effective in reducing transmission, the
economic and social costs of such interventions cast doubt on
their long-term tenability.1 At the same time, countries in-
creased hospital capacity to treat COVID-19 patients, with the
opening of field hospitals, reorganization of health services
and the cancellation of elective surgery. Nonetheless, many
European countries still reported strains on intensive care unit
(ICU) resources owing to a surge in demand.2–4
Healthcare demand is generally greatest during winter.5
Healthcare systems must be prepared to deal with this in
addition to likely increases in numbers of COVID-19
patients requiring hospitalization in winter 2020–2021.6–8
The number of patients in ICUs will be heavily dependent
on population behaviour and the effectiveness of NPIs.
However, few studies have linked forecasts of COVID-19
healthcare demand under NPIs to national-level estimates
of hospital capacity and utilization (e.g. 9–11).
Here, we integrate a hospital capacity framework12,13
with epidemiological projections of COVID-19 patients
requiring ICU treatment14 in three European countries that
have been heavily affected by the pandemic. We present a
scenario-based analysis of the spare capacity of ICU beds,
ventilators and staff in France, Germany and Italy over the
winter period 2020–2021 under a ‘dual-demand’ (COVID-
19 and non-COVID-19) patient model. We examine the ef-
fect of suppression strategies of varying effectiveness that
are triggered based on different levels of ICU occupancy by
COVID-19 patients.
Methods
We estimate the spare capacity, defined as the difference
between the number of patients that can be accommodated
in the ICU and the number of patients requiring ICU care,
of four essential resources: beds, ventilators, nurses and
doctors. We apply our analysis to France, Germany and
Italy.
Parameterizing the capacity model
The capacity framework includes a ‘dual-demand’ model
of care requirements incorporating demand from COVID-
19 and non-COVID-19 cohorts. The former is projected
under different epidemiological scenarios whereas the
Key Messages
• Without mitigation, the number of coronavirus disease 2019 (COVID-19) patients estimated to require intensive care
in winter 2020–2021 will exceed the peak of the first wave and result in capacity deficits.
• Non-pharmaceutical interventions to suppress the transmission of SARS-CoV-2, triggered when the number of
COVID-19 patients in intensive care exceeds a defined threshold, can produce substantial reductions in capacity
deficits, particularly when triggered earlier and sustained under a higher level of suppression.
• Beds are consistently the most constrained intensive care unit resource.
• Mitigation of demand for intensive care must be weighed against the feasibility of suppression interventions and
drawbacks of the intensity and duration of lockdown.
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latter is estimated using average annual occupancy figures.
The requirements of each resource are calculated per pa-
tient, with multiple data sources used to parameterize the
model (Table 1).23–33
There is a one-to-one relationship between patients and
beds. On average, only 42% of non-COVID-19 and 68%
of COVID-19 patients were estimated to receive mechani-
cal ventilation.25,26 Ratios of staff full-time equivalents
(FTEs) per occupied bed were informed by recommended
staff-to-patient ratios,27–32 with maxima of 2.5 ICU beds
per nurse and 8 ICU beds per doctor assigned uniformly
across countries. Staff availability is reduced using a staff-
sickness rate to account for the impact of the virus on the
workforce. These were calculated for each country using
population-infection rates and a modified hazard rate for
healthcare workers. This rate remains constant throughout
the projection period.
Model equations and an illustration of the relationship
between bed demand and deficits are provided in the
Supplementary Material (Supplementary Figure 1, avail-
able as Supplementary data at IJE online).
Estimating pre-pandemic baseline capacity
Baseline national ICU resources were estimated based on
pre-pandemic levels. Data were derived from recent official
publications from the Ministries of Health and the
Organisation for Economic Cooperation and Development
(OECD), where available (Table 1).15,18,20,22
The baseline occupancy of non-COVID-19 patients was
determined using the average annual occupancy of ICU
beds. Whereas admissions are often seasonal, this year, it is
unclear whether winter increases will occur due to measures
to reduce SARS-CoV-2 transmission and reductions in the
non-COVID-19 patient care-seeking behaviour due to the
pandemic.34,35 Therefore, figures for the average annual
ICU occupancy of non-COVID-19 patients were considered
the upper bound for this variable, with alternative scenarios
also explored (see the ‘Modelled scenarios’ section).
Epidemiological models
Epidemiological projections were performed by country
using a previously published stochastic compartmental age-
structured Susceptible-Exposed-Infected-Recovered model
of SARS-CoV-2 transmission.14 The model estimates the
number of cases going through different severity pathways
of COVID-19 disease over time. The model is fitted to daily
reported COVID-19 deaths from the European Centre for
Disease Prevention and Control (ECDC)36 in a Bayesian
framework (see Supplementary Material, available as
Supplementary data at IJE online, epidemiological models
for further details).37 For all analyses conducted, the pack-
age squire v0.4.34 was used.38
To tailor the model to capture the dynamics in mortality
and ICU demand in each country, the following changes
were made to the default model parameters. For France, we
used the age-dependent infection fatality ratio (IFR), the
probability of hospitalization and the probability of requir-
ing an ICU bed given hospitalization estimated in a previous
analysis of the first epidemic wave in France.39 For Italy, we
used the same parameters as for France except that we incor-
porated a higher IFR as recently estimated from seropreva-
lence surveys.40 For Germany, no changes were made to the
default model parameters, which sufficiently captured the
dynamics in mortality and ICU demand. For all countries,
we observed substantial triaging practices to ensure that ICU
bed demand did not exceed capacity during the first peak,
which we captured in the model by fitting a shorter duration
of ICU stay during the first peak. The epidemiological mod-
els were assessed according to their fit to both official
COVID-19 death data41 and ICU demand data.25,41
Modelled scenarios
The calibrated model was used to project ICU demand
from COVID-19 patients under different scenarios from
25 October 2020 to 1 March 2021, assuming no substan-
tial impact from potential vaccines in this period. The
spare capacity of each resource was then calculated under
each of the 100 model simulations for every day of the pro-
jection period.
COVID-19 ICU demand, and by extension spare capac-
ity, was modelled under an unmitigated (no intervention)
scenario and a set of lockdown scenarios in which suppres-
sion interventions reduced SARS-CoV-2 transmission,
expressed as reductions in the time-varying reproduction
number Rt. We investigated a trigger-based approach to
the initiation of lockdown, implemented when the number
of ICU beds required by COVID-19 patients exceeds a pro-
portion of total baseline ICU bed provision (either 1/5, 1/4,
1/3 or 1/2). The length of each triggered lockdown was
varied between 2 to 6 weeks and under two levels of sup-
pression. First, it was assumed that subsequent lockdowns
were as effective as the initial lockdown of spring 2020 in
each country, defined as the lowest Rt estimated during
this period. Second, given that the reduction in Rt likely to
be observed in future lockdowns is ambiguous, we also ex-
plore a higher Rt ¼ 0.8 during lockdowns. This may reflect
the lighter suppression measures implemented, weaker ad-
herence to such policies by the population and the emer-
gence of more-transmissible variants of the virus that are
more difficult to control. During periods of no lockdown,
Rt is assumed to return to its estimated value on 25
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Table 1 Baseline capacity of intensive care unit (ICU) resources in France, Germany and Italy, and parameters of the capacity
model with sources. Details are provided where definitions and measurement methods of ICU capacity vary between countries
Country Variable Value Year of
estimate
Details Source
France Total beds 10 640 2018 Bed ratio per 100 000 population applied
to 2020 population size. Number includes
‘reanimation’ beds for adults except for




(OECD) Intensive Care Beds
Capacity15
Population Division of the
Department of Economic and
Social Affairs of the United
Nations Secretariat16
Bed occupancy (%)a 87% 2011 Published country-wide study of
ICU wards17
Total doctors (FTE) 2047 2018 Data represent annual average full-time
equivalents (FTEs) of doctors of various
specialties working in ICU. Excludes doc-
tors who are still in training (‘internes’).
Ministry of Health Annual
Statistic of Health Establishments
(SAE)18
Total nurses (FTE) 12 332 2018 Data represent annual average FTEs of all
nurses working in ICU (irrespective of
their employer). Includes nurses with and
without specialization.
Ministry of Health SAE18
Total ventilators 7241 2009 Estimated by applying ratio of ventilators
per ICU bed reported in 2009 to the 2018
number of ICU beds. Data represent
(fixed and mobile) ventilators in ICUs
only.
Survey by the Ministry of Health19
Germany Total beds 28 403 2017 Bed ratio per 100 000 population applied
to 2020 population size. Number includes
paediatric ICU beds.
OECD Intensive Care Beds
Capacity15
Population Division of the
Department of Economic and
Social Affairs of the United
Nations Secretariat16
Bed occupancy (%)a 79% 2017 Federal Statistical Office20
Total doctors (FTE) 15 944 2015 Estimated by applying average ICU doc-
tor FTE per hospital to the total number
of hospitals in 2015 and scaled to 2017
assuming same increase as for ICU beds
between 2015 and 2017. It is unclear
whether this estimate includes junior
doctors.
Report from the German Hospital
Institute21
Total nurses (FTE) 58 206 2015 Estimated by applying the ratio of ICU
nurse FTEs per ICU beds reported in
2015 to the 2017 number of beds.
Report from the German Hospital
Institute21
Total ventilators 25 000 2020 Represents number of ventilators before
the coronavirus disease 2019 (COVID-
19) pandemic.
COVID-19 Health Systems
Response Monitor, citing Ministry
of Health3
Italy Total beds 5200 2020 Bed ratio per 100 000 population applied
to 2020 population size. Value represents
the approximate number of beds in
Italian ICUs at the beginning of the
COVID-19 pandemic.
OECD Intensive Care Beds
Capacity15
Population Division of the
Department of Economic and
Social Affairs of the United
Nations Secretariat16
Bed occupancy (%)a 48% 2017 Ministry of Health22
Total doctors (FTE) 2415 2017 Ministry of Health22
(Continued)
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Table 1 Continued
Country Variable Value Year of
estimate
Details Source
Data on doctors employed in ICUs were
not directly available. An estimate of the
headcount of ICU doctors was derived by
applying the proportion of hospital doc-
tors working in ICUs from Spain (2.9%)
to the total doctors employed in hospitals
in Italy. Converted to FTE using the mul-
tiplier derived from OECD physician data
set.b
Total nurses (FTE) 5841 2017 Data on nurses employed in ICUs were
not directly available. An estimate of the
headcount of ICU nurses was derived by
applying the proportion of hospital doc-
tors working in ICUs from Spain (2.9%)
to the total nurses employed in hospital in
Italy. Converted to FTE using the multi-
plier derived from OECD nurse data set.b
Ministry of Health22
Total ventilators 17 011 2017 Ministry of Health22
Hospital-capacity-model parameters
France Staff sickness 14.6% 2020 The daily population-infection risk was
determined using the European Centre for
Disease Prevention and Control (ECDC)
14-day cumulative number of COVID-19
cases per 100 000 and country-population
estimates. This risk was inflated for
healthcare workers, who are estimated to
be 3.4 times more likely to be infected
than the general population.
ECDC COVID-19 data23
Nguyen et al.24Germany Staff sickness 3.3% 2020





68% The mean daily proportion of COVID-19
ICU patients using a ventilator was calcu-
lated from daily situation reports pub-
lished between 1 April and 10 June 2020.
Robert Koch Institut25




42% Proportion of patients with >24 hours’
stay in ICUs on mechanical ventilation on
the assessment day.
Study in German ICUs26
All ICU bed-to-nurse
ratio
2.5:1 Recommended or official ICU bed-to-




8:1 Recommended ICU bed-to-doctor ratio
based on review of evidence from various
countries.
Faculty of Intensive Care
Medicine31,32
aTaken as the upper bound of this variable. Reductions in the deficit in capacity threshold (30% reduction in these figures to represent cancellation of electives
and 0% non-COVID-19 occupancy) were considered in order to account for uncertainty surrounding the demand for care from non-COVID-19 patients this win-
ter (see the ‘Modelled scenarios’ section).
bIn the absence of country-specific data, a multiplier to convert headcounts to FTE was derived from the 2017 OECD data sets of ‘Physicians employed in hos-
pital’ and ‘Professional nurses and midwives employed in hospitals’ by taking the median multiplier for all Western European countries (0.896 and 0.868,
respectively).33
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October 2020. Lastly, we explored the impact of lockdowns
being implemented in a non-reactive strategy, instead being in-
troduced at the beginning of November for 2, 4 or 6 weeks be-
fore being lifted and re-implemented after 4 or 6 weeks,
performed under the same two suppression Rt values as above.
Estimates of spare capacity over time and maximum defi-
cits are presented as the median and 95% credible intervals
(2.5th and 97.5th centiles) from the 100 spare capacity curves.
Deficits in capacity occur when demand exceeds capacity.
Under the baseline parameterization of non-COVID-19 pa-
tient ICU occupancy, the deficit threshold is defined by spare
capacity falling below zero. Reductions in this threshold,
resulting from decreases in non-COVID-19 occupancy, were
evaluated in sensitivity analyses. Both a 30% reduction in
baseline bed occupancy representing the cancellation of elec-
tive surgery13,42 and the removal of all non-COVID-19
patients were considered. The latter provides an upper bound
on capacity rather than a realistic policy option. These alter-
native thresholds were calculated by subtracting the number
of each resource freed under these occupancy levels from
zero (the baseline threshold). Lastly, to characterize the
impact of different lockdown triggers and length of lock-
downs, we compare the overall mean spare capacity of beds
throughout the projection period, the mean number of days
with bed deficits and the mean total time spent in lockdown
from the same 100 spare capacity curves.
Results
Baseline capacity
Baseline ICU capacity data were publicly available from
official government publications, the OECD or academic
papers, with the most recent data being from 2017–2018
(Table 1). The total number of baseline beds alongside an-
nual average pre-pandemic non-COVID-19 occupancy is
illustrated in Figure 1A.
COVID-19 ICU demand
The calibrated epidemiological models accurately repro-
duced patterns of national counts of COVID-19 deaths and
Figure 1 Drivers of the differences of spare capacity estimates in France, Germany and Italy. (A) The number of intensive care unit (ICU) beds and av-
erage annual non-coronavirus disease 2019 (non-COVID-19) patient occupancy at baseline. (B) The estimated minimum value of the effective repro-
duction number (Rt) from the implementation of the first national lockdown (occurring in March 2020 in Italy; May 2020 in France and Germany) with
95% credible intervals. (C) The daily number of confirmed COVID-19 cases across August to November 2020 (D) The daily number of COVID-19 regis-
tered deaths across August to November 2020.
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patients receiving ICU care in France, Germany and Italy25,41
(Supplementary Figure 2, available as Supplementary data at
IJE online). In each country, the unmitigated scenarios suggest
that the number of COVID-19 patients in ICUs would exceed
those seen during the first epidemic wave in each country be-
tween March and June 2020 (Supplementary Figure 3, available
as Supplementary data at IJE online). France and Italy are esti-
mated to observe a second peak ahead of Germany, which is
partly due to the greater number of confirmed cases and deaths
in France and Italy recently (Figure 1C and D)15.
Predictive validity
At the time of review (January 2021), it was possible to vali-
date our simulated COVID-19 ICU demand against true num-
bers of COVID-19 patients in intensive care throughout 25
October–31 December 2020 (Supplementary Figure 4, avail-
able as Supplementary data at IJE online). During our simula-
tion period, all three countries implemented NPIs to suppress
the transmission of SARS-CoV-2.2–4 Consequently, in each
country, observed ICU demand falls comfortably within the
range of modelled scenarios, with no country following the
trajectory of the unmitigated scenario.
Our simulations provide an illustration of the impact of
possible mitigation scenarios as opposed to providing a
prediction of epidemic progression in this period. NPIs are
not implemented following an exact trigger threshold as in
this study. As such, we hypothesize that differences in the
timing and nature of interventions implemented, as well as
observed regional variation in demand for ICU resour-
ces,43,44 explain the small differences between our simula-
tions and that which was observed. For example, in
France, simulated peak demand under the largest trigger
threshold is of a similar magnitude to that which is ob-
served but occurs later due to lockdown being imple-
mented later in the simulation than in reality,2 whereas, in
Germany, the instigation of national lockdown coincided
with the date modelled for the lowest trigger threshold
(mid-December),3 which closely followed the observed
demand.
Spare capacity in ICUs
Model results of ICU capacity constraints in France,
Germany and Italy under no mitigation and different sup-
pression scenarios sustained for 4 weeks when triggered
Figure 2 Spare capacity estimates (median; 95% credible intervals) for France. (A) The unmitigated scenario. (B) The four reactive lockdown scenarios
under two different suppression levels (stronger: lockdown effective reproduction number (Rt) ¼ 0.58; weaker: lockdown Rt ¼ 0.8) and specified lock-
down length of 4 weeks. Grey-shaded areas indicate periods in which lockdowns are implemented, with horizontal coloured lines indicating the corre-
sponding lockdown strength under which this was triggered. The dashed line (spare capacity ¼ 0) indicates the threshold between positive spare
capacity and a deficit in capacity. The dot-dashed and dotted lines indicate an effective reduction in this threshold owing to the cancellation of elective
surgery and the removal of all non-coronavirus disease 2019 (non-COVID-19) patients, respectively, allowing the reallocation of resources to COVID-
19 patients. ICU, intensive care unit.
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are shown in Figures 2–4. Across countries, beds were con-
sistently the most constrained resource. Without mitigation
of the pandemic, all three countries are estimated to expe-
rience substantial shortages of ICU beds over the winter
season (Table 2), with the median maximum deficits corre-
sponding to the same number as the baseline bed capacity
in Germany and France and 2.7 times the baseline bed ca-
pacity in Italy. In France and Italy, bed deficits were pro-
jected to last for almost the entire winter season, peaking
in January, whereas, in Germany, they start in around
December and continue to grow throughout the projection
period.
Ventilators reached smaller median maximum deficits
of 5000 and 9500 under the unmitigated scenario in
France and Germany, respectively. The projections suggest
no staff shortages in Germany, in contrast to a median
maximum deficit of 941 doctor FTEs in France and 201
doctor FTEs and 2401 nurse FTEs in Italy (Table 2).
However, reduction in baseline occupancy through the
cancellation of elective surgery was estimated to be suffi-
cient to restore the positive spare capacity of staff and ven-
tilators (Figures 2–4). Similarly, with strong suppression
measures in the lockdown scenarios, our estimates suggest
that these resources generally would not reach a deficit
(Table 2).
The modelled suppression scenarios highlight the large
effect that reactive lockdown measures can have on miti-
gating shortfalls in ICU bed capacity. For a 4-week lock-
down as effective as during the first peak, the magnitude
and duration of shortages in ICU bed capacity varied
across countries and trigger thresholds, but reductions
compared with the unmitigated scenario were large
throughout (Table 2 and Figures 2–4). Depending on the
trigger threshold, the lockdown scenario reduced the me-
dian maximum bed deficits by between 56–89% and 65–
96%, and reduced the median duration of deficits by be-
tween 33–65% and 30–81% in France and Germany, re-
spectively. In Italy, reactive lockdowns only resulted in
deficits in beds for the highest ICU trigger threshold.
Under the 1/2 ICU capacity trigger threshold lockdown
scenario, remaining median maximum deficits of 4741,
10 805 and 889 beds (representing 45%, 38% and 17% of
baseline bed capacity) in France, Germany and Italy, re-
spectively, were estimated to be prevented by additional
Figure 3 Spare capacity estimates (median; 95% credible intervals) for Germany. (A) The unmitigated scenario. (B) The four reactive lockdown scenar-
ios under two different suppression levels (stronger: lockdown effective reproduction number (Rt) ¼ 0.35; weaker: lockdown Rt ¼ 0.8) and specified
lockdown length of 4 weeks. Grey-shaded areas indicate periods in which lockdowns are implemented, with horizontal coloured lines indicating the
corresponding lockdown strength under which this was triggered. The dashed line (spare capacity ¼ 0) indicates the threshold between positive
spare capacity and a deficit in capacity. The dot-dashed and dotted lines indicate an effective reduction in this threshold owing to the cancellation of
elective surgery and the removal of all non-coronavirus disease 2019 (non-COVID-19) patients, respectively, allowing the reallocation of resources to
COVID-19 patients. ICU, intensive care unit.
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reductions in baseline ICU occupancy through the cancel-
lation of elective surgery on average (Figures 2–4).
Effect of varying trigger thresholds, duration and
effectiveness on the impact and time in lockdown
The impact of and total time spent under a reactive lock-
down were compared under different assumptions of trig-
ger thresholds, lockdown duration and effectiveness.
Spare ICU bed capacity varied substantially between
scenarios using the highest and lowest lockdown trigger
thresholds. In France and Germany, the highest trigger
threshold resulted in increases of three and nine times the
maximum deficits under the lowest thresholds, respectively
(Table 2), and the lowest trigger threshold consistently
resulted in the shortest time with a shortage of beds
(Figure 5). In Italy, the lowest trigger threshold similarly
resulted in the largest median spare ICU bed capacity over
the projection period and bed deficits were prevented alto-
gether under all but the 1/2 ICU capacity threshold. This
difference between countries is largely explained by the
substantially lower baseline occupancy of ICU beds in Italy
by non-COVID patients (48%) compared with France
(87%) and Germany (79%) (Figure 1A). The lower base-
line occupancy affords reactive strategies more time for the
impact of lockdown measures to have an effect before
reaching capacity limits.
Altering the length of each lockdown by between 2 and
6 weeks resulted in minimal reductions in the maximum
deficits under equivalent scenarios (Supplementary Figures
5–10 and Supplementary Tables 2–3, available as
Supplementary data at IJE online). This is largely due to
lockdowns needing to be implemented immediately in the
scenarios with the lowest ICU trigger thresholds, reflecting
that ICU demand was already high at the beginning of the
projection period. However, the average spare ICU bed ca-
pacity tended to increase with lockdown length, notably in
France, whereas the relationship between lockdown length
and number of days in deficits varied by country. In
Germany, the number of days of bed deficits are not depen-
dent on lockdown length due to the particularly low level of
Rt achieved during the first lockdown (Figures 1B and 5).
A lockdown sustained at a lower level of suppression
also resulted in only small increases in the maximum bed
deficits compared with the stronger lockdown for a given
trigger threshold (Table 2), except for in Germany, where
Figure 4 Spare capacity estimates (median; 95% credible intervals) for Italy. (A) The unmitigated scenario. (B) The four reactive lockdown scenarios
under two different suppression levels (stronger: lockdown effective reproduction number (Rt) ¼ 0.6; weaker: lockdown effective reproduction num-
ber (Rt) ¼ 0.8) and specified lockdown length of 4 weeks. Grey-shaded areas indicate periods in which lockdowns are implemented, with horizontal
coloured lines indicating the corresponding lockdown strength under which this was triggered. The dashed line (spare capacity ¼ 0) indicates the
threshold between positive spare capacity and a deficit in capacity. The dot-dashed and dotted lines indicate an effective reduction in this threshold
owing to the cancellation of elective surgery and the removal of all non-coronavirus disease 2019 (non-COVID-19) patients, respectively, allowing the
reallocation of resources to COVID-19 patients. ICU, intensive care unit.
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the lockdown during the first peak was particularly effec-
tive (Figure 1B). However, expected bed deficits persisted
for longer under the weaker lockdown scenarios in all
three countries, despite the total time in lockdown gener-
ally increasing under each trigger strategy (Supplementary
Figure 11, available as Supplementary data at IJE online).
The total time spent in lockdown in France and Italy over
the projection period increases slightly under lower trigger
thresholds (Figure 5). In Germany, the effectiveness of the first
lockdown results in a similar amount of time in lockdown un-
der different trigger thresholds. In Italy, the similarity in the 2-
and 4-week lockdown length scenarios reflects that successive
lockdowns are quickly implemented in the 2-week lockdown
scenario, with a 2-week lockdown unable to reduce transmis-
sion enough to reduce demand below the ICU trigger
threshold. The comparatively lower assumed total ICU capac-
ity in Italy (5200 beds) compared with France (10 640 beds)
and Germany (28 403 beds) also resulted in more frequent
lockdowns being implemented in Italy, with almost 6 weeks
predicted to be spent in lockdown before 1 March.
Lockdowns of pre-determined fixed start and end dates were
generally estimated to have a similar effect on reducing deficits,
but with small increases in the total amount of time spent in
lockdown (Supplementary Figures 12–14, available as
Supplementary data at IJE online).
Discussion
In this study, we examined potential constraints of four
key ICU resources in France, Germany and Italy under
Figure 5 Impact of the duration and timing of lockdowns on the spare capacity of intensive care unit (ICU) beds. The effect of lockdown length on the
average spare capacity of ICU beds; the number of days with a deficit in ICU beds and the total number of days spent in lockdown are shown for
France, Germany and Italy under the stronger-suppression scenarios (France: effective reproduction number (Rt) ¼ 0.58; Germany: Rt ¼ 0.35; Italy: Rt
¼ 0.6). For each plot, the mean of 100 simulation repetitions over the projection period (25 October 2020–1 March 2021) is shown.
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different epidemic scenarios over the winter of 2020–2021.
The unmitigated scenarios resulted in COVID-19 ICU pa-
tient numbers exceeding those seen in the first peak, thus
inducing capacity deficits. Triggered lockdown scenarios
substantially reduced these deficits. Our study found that,
across all epidemic scenarios, beds are consistently the
most constrained ICU resource. Projections of constraints
in doctors, nurses and ventilators varied across countries,
but were found to be manageable through the implementa-
tion of lockdowns, as well through reductions in baseline
bed occupancy, e.g. via the cancellation of elective surgery.
The results suggest that lockdowns triggered based on
ICU occupancy could lead to large increases in spare bed
capacity during the winter compared with no intervention,
reducing deficits in all countries to lower levels that can
then be managed by hospital provision interventions.
Lower trigger thresholds generally minimize deficits by
implementing lockdowns earlier, but their impact is depen-
dent on baseline ICU bed numbers and average non-
COVID-19 patient occupancy. For example, Italy, with a
lower average occupancy, can accommodate greater de-
mand from COVID-19 patients relative to the total ICU
bed capacity. For a given trigger threshold, increasing the
length of lockdown only provides small decreases in the
number of days in deficits. On the other hand, a lockdown
less effective than the first peak reduces deficits compared
with the unmitigated scenario but could also lead to an in-
crease in the amount of time spent in lockdown and the re-
quirement of a lower trigger threshold compared with a
stronger lockdown. Our results highlight the dependencies
between these metrics, suggesting that absolute benefits of
different strategies must be weighed against the feasibility
and drawbacks of an increased amount of time spent in
lockdown.
Our study integrates two critical frameworks of signifi-
cance in the control of the pandemic: hospital capacity esti-
mation and epidemiological simulations. Whereas previous
studies have used epidemiological modelling to project
ICU demand, data on hospital capacity failed to consider
key ICU resources other than beds and the dependencies
between them.12 Further strengths of this study include the
use of a dual-demand model considering changes in de-
mand for ICU care of both COVID-19 and non-COVID-
19 patients, and the incorporation of COVID-19-related
staff sickness that has shown to result in substantial addi-
tional constraints.45 Though countries have differing defi-
nitions of intensive care, our results also provide insights
into how requirements for ICU capacity management may
vary between countries with different healthcare systems
and epidemic trajectories. Specifically, this allows policy-
makers to consider how to combine interventions to allevi-
ate strain on hospital capacity effectively via the use of
NPIs, by reducing the number of non-COVID-19 patients
and increasing ICU capacity through the use of supply-side
provision interventions (see Supplementary Material, avail-
able as Supplementary data at IJE online, for further
discussion).
There are some limitations of this study. First, data
were sometimes missing or of low quality. Due to poor
documentation at the national level, it was not possible to
quantify the expansion of hospital capacity during the first
peak of COVID-19 patients. Capacity deficits may be over-
estimated, although many of the implemented hospital
provision interventions were temporary. Data from the
first peaks in spring 2020 used to parameterize the model,
e.g. ventilation requirements, may have changed due to
changes in clinical practice. For example, the use of dexa-
methasone for treating individuals receiving oxygen has
been shown to decrease COVID-19 mortality.46 Data on
the use of dexamethasone over time in each country are
lacking; the resultant reduction of IFR would lead to an in-
creased ICU demand in order to reproduce the observed
mortality. This could be the explanation for our slight un-
derestimation of ICU demand at the beginning of the sec-
ond wave (Supplementary Figures 2 and 4, available as
Supplementary data at IJE online). Second, modelled esti-
mates of the spare capacity of nurses and doctors are likely
to be uncertain as ward-based bed-to-staff ratios have pre-
viously been shown to be inconsistent in approximating
national staffing requirements47,48 and there is no single
recommended methodological standard for staff ratios
across the countries.49 However, our unmitigated scenario
results broadly align with a recent study analysing health-
care pressure in Europe due to the COVID-19 pandemic.50
Third, the model does not account for cohorting of
COVID-19 and non-COVID-19 patients within hospitals,
which likely reduces available resources, but this will vary
between hospitals and is beyond the scope of this analysis.
Fourth, whereas Rt may not remain constant during lock-
down periods, we made this simplifying assumption to
avoid having a confusing number of alternative scenarios.
This means that we did not account for the emergence of
more-transmissible variants of SARS-CoV-2 during the
simulation period, which may increase pressure on health
services despite implemented lockdown measures.
However, our scenarios broadly encompass true COVID-
19 ICU demand within each country in November and
December 2020 (Supplementary Figure 4, available as
Supplementary data at IJE online). Fifth, the comparison
between different lockdown triggers and lengths is limited
by having a fixed end date for comparison (1 March
2021). Consequently, the timing of lockdowns within this
evaluation period leads to non-monotonic relationship be-
tween lockdown length and the spare capacity of ICU
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beds. Lastly, we do not consider the impact of vaccines.
COVID-19 vaccines were approved for use across Europe
in December 2020.51 However, over the time period that
we consider, vaccination will have a very small effect, due
to the time taken for a significant proportion to receive the
vaccine and then develop immune protection.
While the trajectory of the COVID-19 pandemic over
winter is unknown, our findings suggest that a combina-
tion of strategies will be required to overcome potential
ICU capacity deficits and ensure the treatment of all
patients, regardless of COVID-19 status, in France,
Germany and Italy. Although this analysis focused on these
three countries, similar questions surrounding the required
winter interventions must now be answered across Europe,
with substantial second waves being observed across the
continent, which have eclipsed the first wave in several
countries. The large trade-offs inherent in each strategy
should not be underestimated and continuous decision-
making by national policymakers will be required across
the winter period 2020–2021.
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